COVID-19 Monoclonal Antibody Therapeutics

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens.  Two products have been granted emergency use authorization by the Food and Drug Administration.  Read more about available therapies using the links below.